Pesticide spraying: Image extracted from the CTV News video below.

Pesticide spraying: Image extracted from the CTV News video below.

This is an update to these previous blogs:

The following video presents 2013 09 26 – TV News Story – Canadian Bee Crisis:

“Environmental groups want federal Health Minister Rona Ambrose to reconsider Health Canada’s decision to re-approve a pesticide — severely restricted in Europe and linked to massive bee die-offs in Canada — for use on fruits, potatoes and turf. Lawyers from the Canadian Environmental Law Association and Ecojustice have filed a Notice of Objection with the health minister on behalf of Sierra Club Canada, Wilderness Committee, David Suzuki Foundation and Équiterre. The objection concerns Health Canada’s recent decision to renew the registration for clothianidin, a neonicotinoid pesticide toxic to bees, which the groups say should be banned in Canada.

Over the past two years, massive bee die-offs reported in Manitoba, Ontario and Quebec were linked to the use of neonicotinoid pesticides. In addition, a growing body of scientific literature documents the adverse effects of neonicotinoids on the foraging and homing behaviour of bees, as well as metabolic, immune and reproductive functions.”

Ontario is taking the strongest action in North America to protect bees, birds, butterflies, and other pollinators by proposing new rules that would reduce the number of acres planted with neonicotinoid-treated corn and soybean seeds by 80 per cent by 2017.

  • Some neonicotinoid insecticides are toxic to bees and other beneficial insects.
  • In the winter of 2013-2014, bee deaths in Ontario reached 58 per cent. The generally accepted level by those who care for and breed bees is 15 per cent.
  • Bees and other pollinators are responsible for pollinating roughly 13 per cent of agricultural crops in Ontario (crops worth about $897 million), and support $26 million annually in honey production.
  • Ontario’s agri-food sector employs 760,000 individuals and contributes $34 billion each year to the province’s economy.

“A comprehensive Pollinator Health Action Plan would improve the state of pollinator health in Ontario and strengthen their populations. The plan we are proposing to develop will promote a sustainable food supply, healthy ecosystems and a strong economy.”

The proposed regulation sets rules for the sale and use of neonicotinoid-treated corn and soybean seeds.

  • The amendments to Ontario Regulation 63/09, under the Pesticides Act would establish:
    • a new class of pesticides consisting of corn and soybean seeds treated with the neonicotinoids, imidacloprid, clothianidin or thiamethoxam,
    • rules for the sale and use of treated seeds,
    • timing and implementation of the regulatory requirements.

The draft regulation is available for public comment on the environmental registry until May 7, 2015. You can submit your comments in the following three ways: Read more of Ontario’s Rules to Reduce Neonicotinoid Pesticide: Protect Bees: Submit Comments Until May 7, 2015

Above, CFIA's Electron Microscope Image of Salmonella bacteria. (In reality Salmonella is not pink; the pink colour is added as visual aid.)

Above, CFIA’s Electron Microscope Image of Salmonella bacteria. (In reality Salmonella is not pink; the pink colour is added as visual aid.)

The Canadian Food Inspection Agency (CFIA) is warning the public not to consume and retailers not to sell the Aurora brand Cranberry Health Mix described below due to Salmonella bacteria.

  • This warning was triggered by a recall in the United States.

Please click here for the description and photos of the affected product.

The other details of this recall are as follows. Read more of Health Hazard Alert: Aurora Brand Cranberry Health Mix is Recalled

Mondelez Canada Inc. is voluntarily recalling select 300 g and 500 g Christie brand Golden Oreo Cookies from the marketplace due to an incorrect carbohydrate declaration on the Nutrition Facts table.

  • This recall was triggered by consumer complaints.
  • Affected products declare 8 g of carbohydrate per serving, but contain 17 g of carbohydrate per serving.
  • People who are monitoring blood glucose levels and carbohydrate consumption should be aware that the amount of carbohydrate in a serving is 17 g, not 8 g as indicated on the label, or should not consume the recalled products.

Please click here for the description and photos of the affected products.

The other details of this recall are as follows. Read more of Health Hazard Alert: Christie Brand Golden Oreo Cookies are Recalled

Canadian Food Inspection Agency

Canadian Food Inspection Agency

Industry is recalling various products containing organic garlic powder from the marketplace due to possible Salmonella bacteria contamination.

Consumers should not consume the recalled products.

The other details of this recall are as follows. Read more of First and Second Lists of Recalled Products Containing Organic Garlic Powder

Above, CFIA's Electron Microscope Image of Salmonella bacteria. (In reality Salmonella is not pink; the pink colour is added as visual aid.)

Above, CFIA’s Electron Microscope Image of Salmonella bacteria. (In reality Salmonella is not pink; the pink colour is added as visual aid.)

Transilvania Trading is recalling Trader Joe’s brand walnuts from the marketplace due to possible Salmonella bacteria contamination.

  • Consumers should not consume the recalled products.

Please click here for the description and photos of the affected products.

The other details of this recall are as follows. Read more of Health Hazard Alert: Trader Joe’s Brand Walnuts are Recalled

This is an update to the previous blog, Fujifilm’s Technology in Photo Development Will Be Used to Develop a Rapid Diagnostic System for Ebola Virus Disease.

This video presents Ebola update new flu drug tested on patient 10 06 2014 #ebola.

Fujifilm Avigan® Tablet 200mg* (Favipiravir) tablets: image extracted from video above

Fujifilm Avigan® Tablet 200mg* (Favipiravir) tablets: image extracted from video above

“Taking this medicine as early as possible (means) the mortality rate can be significantly reduced….”

There are no drugs on the market to treat Ebola, which has ravaged West Africa and killed 9,177 of the nearly 23,000 people infected since late 2013. Clinical trials of other experimental drugs are underway but are at an earlier stage…”

http://www.japantimes.co.jp/news/2015/03/03/national/science-health/japanese-firm-behind-ebola-drug-says-results-clinical-trials-offer-hope/#.VQj3v0ZCCPR

NEWS RELEASE

Efficacy of Avigan® Tablet 200mg as a treatment for Ebola virus disease (EVD) suggested in clinical trial (interim analysis)

February 24, 2015

FUJIFILM Corporation (President: Shigehiro Nakajima) announced that the French National Institute of Health and Medical Research (Inserm) ** released today an interim analysis of the clinical trial suggesting the efficacy of anti-influenza drug Avigan® Tablet 200mg* (Favipiravir), which is being provided to clinical trials in Guinea for patients with Ebola Virus Disease (EVD). Read more of Fujifilm’s Avigan 200mg (Favipiravir): Efficacy as a Treatment for Ebola Virus Disease is Suggested

Panasonic's medical robots

Panasonic’s medical robots

This video presents Panasonic Solutions Report 04 “Health Care Solution”.

Health care providers around the world are looking for ways to alleviate the workloads of nursing staff stretched to the limits. Can robot automation help improve quality of nursing and raise expectations for a viable solution? A hospital in Osaka, Japan is doing just that. It is testing “HOSPI”―an autonomous delivery robot for hospitals―which provides new solutions for health care. Business journalist Mike Firn reports from the scene.

Solution Report of HOSPI

Panasonic "HOSPI" is an autonomous delivery robot for hospitals

Panasonic “HOSPI” is an autonomous delivery robot for hospitals

PRESS RELEASE

Panasonic Joins Thai Project, “Center for Advanced Medical Robotics”

Mar 09, 2015

Bangkok, Thailand - Panasonic’s New Business Promotion Project of Global Manufacturing Division and Analysis Center have recently joined the national robotics project “Center for Advanced Medical Robotics” in Thailand. On February 6, 2015, a signing ceremony and media event was held in Bangkok, Thailand with Yoshiyasu Honma, Project Leader of the New Business Promotion Project; Yoshihiko Namba, Director of Analysis Center; and three other members participating.

Front left to right: Mr. Honma, Mahidol University President Udom, TCELS CEO Mr. Nares, and Dr. Namba at the signing ceremony

Front left to right: Mr. Honma, Mahidol University President Udom, TCELS CEO Mr. Nares, and Dr. Namba at the signing ceremony

Read more of Panasonic’s Medical Delivery Robot “HOSPI” in the “Center for Advanced Medical Robotics” in Thailand